1. Table 2. Baseline Demographic and Clinical Characteristics, Safety Population, Trial CDISCPILOT01
  Output: O_T2
  1.1. Summary of Subjects by Treatment
    Analysis: A_SAF_SUM_USUBJID_TRT
      Documentation:
        Reason: SPECIFIED IN SAP
        Purpose: PRIMARY OUTCOME MEASURE
        See:
          > Statistical Analysis Plan (./sap.pdf)
            - Page 9 [6. ANALYSIS POPULATIONS]
      Population: Safety Population [ADSL.SAFFL EQ 'Y']
      Groupings:
        1. Treatment [Results per group: Y]:
           1. Placebo [ADSL.TRT01A EQ 'Placebo']
           2. Xanomeline Low Dose [ADSL.TRT01A EQ 'Xanomeline Low Dose']
           3. Xanomeline High Dose [ADSL.TRT01A EQ 'Xanomeline High Dose']
      Analysis Variable: ADSL.USUBJID
      Method: Count by group for a categorical variable
        Operations:
          > M_GRP_CNT_1_N: Count of subjects (n)
  1.2. Sex
    1.2.1. Summary of Subjects by Treatment
      Analysis: A_SAF_SUM_USUBJID_TRT_SEX
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: Safety Population [ADSL.SAFFL EQ 'Y']
        Groupings:
          1. Treatment [Results per group: Y]:
             1. Placebo [ADSL.TRT01A EQ 'Placebo']
             2. Xanomeline Low Dose [ADSL.TRT01A EQ 'Xanomeline Low Dose']
             3. Xanomeline High Dose [ADSL.TRT01A EQ 'Xanomeline High Dose']
          2. Gender [Results per group: Y]:
             1. Male [ADSL.SEX EQ 'M']
             2. Female [ADSL.SEX EQ 'F']
        Analysis Variable: ADSL.USUBJID
        Method: Summary by group of a categorical variable
          Operations:
            > M_GRP_SUM_CATEG_1_N: Count of subjects (n)
            > M_GRP_SUM_CATEG_2_PCT: Percent of subjects (%)
              - Numerator: result of operation M_GRP_SUM_CATEG_1_N for this analysis
              - Denominator: result of operation M_GRP_CNT_1_N for analysis A_SAF_SUM_USUBJID_TRT
  1.3. Age
    1.3.1. Summary of Age by Treatment
      Analysis: A_SAF_SUM_AGE_TRT
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: Safety Population [ADSL.SAFFL EQ 'Y']
        Groupings:
          1. Treatment [Results per group: Y]:
             1. Placebo [ADSL.TRT01A EQ 'Placebo']
             2. Xanomeline Low Dose [ADSL.TRT01A EQ 'Xanomeline Low Dose']
             3. Xanomeline High Dose [ADSL.TRT01A EQ 'Xanomeline High Dose']
        Analysis Variable: ADSL.AGE
        Method: Summary by group of a continuous variable
          Operations:
            > M_GRP_SUM_CONTIN_1_MEAN: Mean (Mean)
            > M_GRP_SUM_CONTIN_2_SD: Standard deviation (SD)
            > M_GRP_SUM_CONTIN_3_MEDIAN: Median (Median)
            > M_GRP_SUM_CONTIN_4_MIN: Minimum (min)
            > M_GRP_SUM_CONTIN_5_MAX: Maximum (max)
  1.4. Age groups
    1.4.1. Summary of Subjects by Treatment
      Analysis: A_SAF_SUM_USUBJID_TRT_AGEGRP
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: Safety Population [ADSL.SAFFL EQ 'Y']
        Groupings:
          1. Treatment [Results per group: Y]:
             1. Placebo [ADSL.TRT01A EQ 'Placebo']
             2. Xanomeline Low Dose [ADSL.TRT01A EQ 'Xanomeline Low Dose']
             3. Xanomeline High Dose [ADSL.TRT01A EQ 'Xanomeline High Dose']
          2. Age groups [Results per group: Y]:
             1. < 65 [ADSL.AGEGR2 EQ '<65']
             2. ≥ 65 [ADSL.AGEGR2 EQ '65+']
          3. Age sub-groups [Results per group: Y]:
             1. ≥17 to <65 [ADSL.AGEGR3 EQ '17-<65']
             2. ≥ 65 to <75 [ADSL.AGEGR3 EQ '65-<75']
             3. ≥ 75 [ADSL.AGEGR3 EQ '75+']
        Analysis Variable: ADSL.USUBJID
        Method: Summary by group of a categorical variable
          Operations:
            > M_GRP_SUM_CATEG_1_N: Count of subjects (n)
            > M_GRP_SUM_CATEG_2_PCT: Percent of subjects (%)
              - Numerator: result of operation M_GRP_SUM_CATEG_1_N for this analysis
              - Denominator: result of operation M_GRP_CNT_1_N for analysis A_SAF_SUM_USUBJID_TRT
  1.5. Race
    1.5.1. Summary of Subjects by Treatment
      Analysis: A_SAF_SUM_USUBJID_TRT_RACE
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: Safety Population [ADSL.SAFFL EQ 'Y']
        Groupings:
          1. Treatment [Results per group: Y]:
             1. Placebo [ADSL.TRT01A EQ 'Placebo']
             2. Xanomeline Low Dose [ADSL.TRT01A EQ 'Xanomeline Low Dose']
             3. Xanomeline High Dose [ADSL.TRT01A EQ 'Xanomeline High Dose']
          2. Race [Results per group: Y]:
             1. American Indian or Alaska Native [ADSL.RACE EQ 'AMERICAN INDIAN OR ALASKA NATIVE']
             2. Black or African American [ADSL.RACE EQ 'BLACK OR AFRICAN AMERICAN']
             3. Native Hawaiian or Other Pacific Islander [ADSL.RACE EQ 'NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER']
             4. White [ADSL.RACE EQ 'WHITE']
             5. Other [ADSL.RACE NOTIN ('AMERICAN INDIAN OR ALASKA NATIVE', 'BLACK OR AFRICAN AMERICAN', 'NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER', 'WHITE')]
        Analysis Variable: ADSL.USUBJID
        Method: Summary by group of a categorical variable
          Operations:
            > M_GRP_SUM_CATEG_1_N: Count of subjects (n)
            > M_GRP_SUM_CATEG_2_PCT: Percent of subjects (%)
              - Numerator: result of operation M_GRP_SUM_CATEG_1_N for this analysis
              - Denominator: result of operation M_GRP_CNT_1_N for analysis A_SAF_SUM_USUBJID_TRT
  1.6. Ethnicity
    1.6.1. Summary of Subjects by Treatment
      Analysis: A_SAF_SUM_USUBJID_TRT_ETHNIC
        Documentation:
          Reason: SPECIFIED IN SAP
          Purpose: PRIMARY OUTCOME MEASURE
          See:
            > Statistical Analysis Plan (./sap.pdf)
              - Page 13 [9.2. Demographic and Baseline Characteristics]
        Population: Safety Population [ADSL.SAFFL EQ 'Y']
        Groupings:
          1. Treatment [Results per group: Y]:
             1. Placebo [ADSL.TRT01A EQ 'Placebo']
             2. Xanomeline Low Dose [ADSL.TRT01A EQ 'Xanomeline Low Dose']
             3. Xanomeline High Dose [ADSL.TRT01A EQ 'Xanomeline High Dose']
          2. Ethnicity [Results per group: Y]:
             1. Hispanic or Latino [ADSL.ETHNIC EQ 'HISPANIC OR LATINO']
             2. Not Hispanic or Latino [ADSL.ETHNIC EQ 'NOT HISPANIC OR LATINO']
        Analysis Variable: ADSL.USUBJID
        Method: Summary by group of a categorical variable
          Operations:
            > M_GRP_SUM_CATEG_1_N: Count of subjects (n)
            > M_GRP_SUM_CATEG_2_PCT: Percent of subjects (%)
              - Numerator: result of operation M_GRP_SUM_CATEG_1_N for this analysis
              - Denominator: result of operation M_GRP_CNT_1_N for analysis A_SAF_SUM_USUBJID_TRT
